Personal Information

Name
Tse-Ling Fong, M.D., FACP

Business Address
USC Liver Transplant Program and Center for Liver Disease
1510 San Pablo Street
Suite 200
Los Angeles CA 90033-4612

Phone: (323) 442-5908
Fax: (323) 442-5721

• National Board of Medical Examiners, June 1983

• Board Certification
  • American Board of Internal Medicine, September 1985
  • Sub-specialty; Gastroenterology, November 1989

• 1968-1974
  Secondary School
  King George V School
  Hong Kong
  

• 1974-1978
  B.A., (cum laude)
  University of California, San Diego

• 1978-1982
  M.D., University of Southern California
  School of Medicine

1982-1985
Residency, Internal Medicine
LAC/USC Medical Center
Los Angeles, California

1985-1987
Fellowship, Hepatology
USC Liver Unit
Rancho Los Amigos Medical Center
Downey, California

1987-1989
Fellowship, Gastroenterology
LAC/USC Medical Center
Los Angeles, California

1989-1991
Clinical Associate
Liver Diseases Section, NIDDK
National Institutes of Health
Bethesda, Maryland

• 1985-1989
  Clinical Instructor in Medicine
  University of Southern California
  School of Medicine
  Los Angeles, California

• 1991-1996
  Assistant Professor of Medicine
  University of Southern California
  School of Medicine
  Los Angeles, California

• 1996-2001
  Assistant Professor of Medicine
  University of California, Los Angeles
  School of Medicine
  Los Angeles, California

• 2001
  Associate Professor of Medicine
  University of Southern California
  Keck School of Medicine
  Los Angeles, California

• 1991- 1996
  Attending Physician
  LAC/USC Medical Center
  Los Angeles, California

  1991- 1996
  Attending Physician
  Rancho Los Amigos Medical Center
  Downey, California

  1996- 2001
  Associate Medical Director
  Liver Transplantation Program
  Cedars-Sinai Medical Center
  Los Angeles, California

  2001
  Medical Director
  Liver Transplant Program
  USC Keck School of Medicine
  Los Angeles, California

• Provost Honor List 1974-1976, University of California, San Diego

• President's Fellowship for Undergraduate Research, 1977-1978, University of California, San Diego

• National Institute of Mental Health Research Fellowship, 1979-1980, University of Southern California, School of Medicine

• University of Southern California, School of Medicine Research Fellowship 1980-1981

• Sigma-Xi Research Honor Society Research Grant, 1980-1981, University of Southern California, School of Medicine

• Golden Apple Teaching Award 1996-1997, Department of Medicine, Cedars-Sinai Medical Center

• Hepatology 1990-
• Gastroenterology 1991-
• American Journal of Gastroenterology 1994-
• Annals of Internal Medicine 1997-
• Clinical Infectious Disease 1998-

• American College of Physicians, Fellow
• American Association for the Study of Liver Diseases
• American Society of Transplant Physicians
• Western Society for Clinical Investigation
• Southern California Society for Gastroenterology

Cedars-Sinai Medical Center

• Clinical Competency Committee 1997-
• Institutional Review Board 1998-

Southern California Gastroenterology Society

• Councilor 1998-

1. White K, Shih J, Fong T-L, Young H, Gelfand R, Boyd J, Simpson G, Sloane B. Elevated Platelet Monoamine Oxidase Activity in Patients with Nonendogenous Depression. American Journal of Psychiatry 1980;137:1258-1260.

2. Radin R, Fong T-L , Halls J, Pontrelli G. Monilial Enteritis in Acquired Immunodeficiency Syndrome. AJR 1983;141:1289-1290.

3. Fong T-L, De Cock KM, Govindarajan S, Yamada S, Morgan TR, Redeker AG. Clustering of Delta Hepatitis in a Family from Lebanon, Journal of Infectious Diseases 1986;154:912-913.

4. Govindarajan S, Fong T-L, Ashcavai M. Concanavalin A Affinity of Alpha-Fetoprotein - Its Use in Differentiating Tumors. American Journal of Clinical Pathology 1987;88:722-724.

5. Govindarajan S, Fong T-L, Valinluck B, Edwards V, Redeker AG. Markers of Viral Replication in Patients with Chronic Hepatitis B Virus Infection. American Journal of Clinical Pathology 1988;89:233-237.

6. Fong T-L, Govindarajan S, Valinluck B, Redeker AG. Status of HBV-DNA in Alcoholic Liver Disease: A Study of a Large Urban Population in the United States. Hepatology 1988;8:1602-1604.

7. Fong T-L, Warner N, Kumar D. Pancreatic Nesidioblastosis in Adults. Diabetes Care 1989;12:108-114.

8. Fong T-L, Akriviadis E, Runyon BA, Reynolds TB. Polymorphonuclear Cell Count Response and Duration of Antibiotic Therapy in Spontaneous Bacterial Peritonitis. Hepatology 1989;9:423-426.

9. Fong T-L, Akriviadis E, Govindarajan S, Valinluck B, Redeker AG. Serum Hepatitis B Viral DNA in Acute Viral Hepatitis B. Annals of Internal Medicine 1989;110:937-38.

10. Akriviadis E, Steindel H, Pinto P, Fong T-L, Kanel G, Reynolds TB, Gupta S. Failure of Colchicine to Improve Short-Term Survival in Patients with Severe Alcoholic Hepatitis. Gastroenterology 1990;99:811-818.

11. Gupta S, Govindarajan S, Fong T-L, Redeker AG. Spontaneous Reactivation in Chronic Hepatitis B: Patterns and Natural History. Journal of Clinical Gastroenerology 1990;12:562-568.

12. Fong T-L, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons P, Perez-Perez GI, Blaser MJ. Helicobacter Pylori Infection in Pernicious Anemia: A Prospective Controlled Study. Gastroenterology 1991;100:328-332.

13. Fong T-L, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The Significance of Antibody to Hepatitis C Virus in Patients with Chronic Hepatitis B. Hepatology 1991;14:64-67.

14. Fong T-L, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of Replicative Intermediates of Hepatitis C Viral RNA in Liver and Serum of Patients with Chronic Hepatitis C. Journal of Clinical Investigation 1991;88:1058-1060.

15. Fried MW, Shindo M, Fong T-L, Fox P, Hoofnagle JH, Di Bisceglie AM. Absence of HCV RNA from Saliva and Semen in Patients with Chronic Hepatitis C. Gastroenterology 1992;102:1306-1308.

16. Fong T-L, McHutchison JG, Reynolds TB. Hyperthyroidism and Hepatic Dysfunction: A Case Series Analysis. Journal of Clinical Gastroenterology 1992;14:240-244.

17. De Bisceglie AM, Shindo M, Fong T-L, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH. A Pilot Study of Ribavirin Therapy for Chronic Hepatitis C. Hepatology 1992;16:649-654.

18. Fong T-L, Charboneau F, Valinluck B, Govindarajan S. The Stability of Serum HCV RNA in Various Handling and Storage Conditions. Archives of Pathology and Laboratory Medicine 1993;117:150-151.

19. Fong T-L, Valinluck B, Govindarajan S, Rolon N, Lee SR, Page E, Darner J, Redeker AG. Marked Improvement in Sensitivity of Second Generation Tests for Acute Hepatitis C Infection. Journal of Infectious Diseases 1993;168:519-520.

20. Fong T-L, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of HBV DNA in the Liver after Loss of Hepatitis B Surface Antigen from Serum of Patients with Chronic Hepatitis B. Hepatology 1993;18:1313-1318.

21. Di Bisceglie AM, Fong T-L, Fried MW, Swain MG, Baker B, Korenman J, Bergasa NV, Waggoner JG, Park Y, Hoofnagle JH. A Randomized, Controlled Trial of Recombinant Alpha-Interferon Therapy for Chronic Hepatitis B. American Journal of Gastroenterology 1993;88:1887-1892.

22. Person JL, McHutchison JG, Fong T-L, Redeker AG. A Case of Cyclosporin-Sensitive, Steroid Resistant Autoimmune Chronic Active Hepatitis. Journal of Clinical Gastroenterology 1993;17:317-320.

23. Fong T-L, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. The Clinical Significance of Concomitant Hepatitis C Infection in Patients With Alcoholic Liver Disease. Hepatology 1994;19:554-557.

24. Fong T-L, Di Bisceglie AM, Biswas R, Waggoner JG, Wilson L, Claggett J, Hoofnagle JH. High Levels of Viral Replication During Acute Hepatitis B Infection Predict Progression to Chronicity. Journal of Medical Virology 1994;43:155-158.

25. Fried MW, Fong T-L, Swain MG, Park Y, Beames M, Banks SM, Hoofnagle JH, Di Bisceglie AM. Therapy of Chronic Hepatitis B With A 6-Month Course of Ribavirin. Journal of Hepatology 1994;21:145-150.

26. Fong T-L, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Effects of Prednisone Therapy on Aminotransferase Activity and Hepatitis C Virus RNA Levels in Chronic Hepatitis C. Gastroenterology 1994;107:196-199.

27. Shindo M, Di Bisceglie AM, Akatsuka T, Fong T-L, Scaglione L, Donets M, Hoofnagle JH, Feinstone S. The Physical State of the Negative Strand of HCV RNA in Serum of Patients with Chronic Hepatitis C Proceedings of the National Academy of Science USA 1994;91:8719-8723.

28. Fong T-L, Morgan TR, Phan CG, Hoefs JC. Raising the Dose of Interferon Does Not Improve the Response in Chronic Hepatitis C. Journal of Clinical Gastroenterology 1995;20:42-44.

29. Mican JM, Di Bisceglie AM, Fong T-L, Travis WD, Kleiner DE, Baker B, Metcalfe DD. Hepatic Involvement in Mastocytosis: Clinicopathologic Correlations in 41 Cases. Hepatology 1995;22:1163-1170.

30. Fong T-L, Lee SR, Briggs WK, Valinluck B, Govindarajan, S, Hoffman A, Jaczko B, Redeker AG. Clinical Significance of Hepatitis C Viral RNA Status and its Correlation to Antibodies to Structural HCV Antigens in Anti HCV Reactive Patients With Normal Liver Tests. Journal of Medical Virology 1996;49:253-258.

31. Fong T-L, Lee SR, Kim J, Yun AJ, Zheng J, Peterson J, Kochesky R Botla R, Geller SA, Redeker AG. Prevalence of Hepatitis G Virus Among Intravenous Drug Users In Los Angeles. Clinical Infectious Diseases 1997; 25:487-488.

32. Tsai NCS, Zuckerman E, Han S-H, Goad K, Redeker AG, Fong T-L. The Effect of Iron Depletion on Long-Term Response to a-Interferon in Patients with Chronic Hepatitis C Who Previously Did Not Respond to Interferon Therapy. American Journal of Gastroenterology 1997;92:1831-1834.

33. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong T-L. Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin's Lymphoma. Annals of Internal Medicine 1997;127:423-428.

34. Fong T-L, Han S-H, Tsai NC-S, Morgan TR, Mizokami M, Qian D, Phan C, Goad K, Redeker AG. A Pilot Randomized, Controlled Trial of the Effect of Iron Depletion on Long-Term Response to Alfa-Interferon in Patients with Chronic Hepatitis C. Journal of Hepatology 1998;28:369-374 .

35. Fernandes NF, Geller SA, Fong T-L. Terbinafine Hepatotoxicity: Case Report and Review of the Literature. American Journal of Gastroenterology 1998; 93: 459-460.

36. Han S-H, Reynolds TB, Fong T-L. Nephrogenic Ascites: Analysis of 16 Cases and Review of the Literature. Medicine 1998; 77:233-45.

37. Fernandes NF, Redeker AG, Vierling JM, Villamil F, Fong T-L. Cyclosporin Therapy in Patients with Steroid Resistant Autoimmune Hepatitis: A Case Series and Review of the Literature. American Journal of Gastroenterology 1999; 94: 241-8.

38. Fong T-L, Fried MW, Clarke-Platt J. A Pilot Study of Rimantadine for Patients with Chronic Hepatitis C Unresponsive to Interferon Therapy. American Journal of Gastroenterology 1999; 94: 990-93.

39. Kahn JA, Haker KM, Petrovic LM, Arnaout WA, Koobatian G, Fong T-L. Radiographic Findings of Ischemic Hepatitis in a Cirrhotic Patient. Journal of Computer Assisted Tomography 2000;24-887-889.

40. Yu AS, Vierling JM, Colquhoun SD, Arnaout AS, Chan C-K, Khansfshar E, Geller SA, Nichols WS, Fong T-L. Transmission of Hepatitis B Infection from Hepatitis B Core Antibody Positive Liver Allografts is Prevented by Lamivudine Therapy. Liver Transplantation 2001 (in press)

41. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, Steinbrecher UP, Fong T-L. Analysis of Causes of Death in Liver Transplant Recipients who Have Survived More Than Three Years. Liver Transplantation 2001 (in press)

42. Fong T-L, Bunnapradist S, Jordan SC, Cho YC. Impact of Hepatitis B core Antibody Status on Outcomes of Cadaveric Renal Transplantation: Analysis of UNOS Database Between 1994 and 1999. Transplantation 2001 (in press)

1. Fong T-L, Reynolds TB. Polymorphonuclear (PMN) Cell Count Response and Duration of Antibiotic Therapy in Spontaneous Bacterial Peritonitis (SBP). Hepatology 1986;6:1216.

2. Fong T-L, Govindarajan S, Valinluck B, De Cock KM, Redeker AG. Hepatitis B Virus DNA in Alcoholic Disease. Hepatology 1986;6:1216.

3. Fong T-L, Akriviadis E, Govindarajan S, Valinluck B, Redeker AG. Serum HBV-DNA in Acute Hepatitis B Infection. Hepatology 1987;7:1121.

4. Akriviadis E, Steindel H, Pinto P, Fong T-L, Kanel G, Reynolds TB, Gupta S. Failure of Colchicine to Improve Short-Term Survival in Patients with Severe Alcoholic Hepatitis. Hepatology 1988;8:1239.

5. Fong T-L, Dehesa M, Dooley CP, Cohen H, Fitzgibbons P, Carmel R, Perez-Perez GI, Blaser MJ. The Prevalence of Campylobacter Pylori in Patients with Pernicious Anemia. Gastroenterology 1989;96:A154.

6. Fong T-L, Dooley CP, Dehesa M, Cohen H, Fitzgibbons P, Carmel R, Perez-Perez GI, Blaser MJ. Gastritis Types A and B are Distinct Entities. American Journal of Gastroenterology 1989;84:1157.

7. Fong T-L, Di Bisceglie AM, Waggoner JG, Hoofnagle JH. The Significance of Concomitant Chronic Hepatitis B and Hepatitis C Virus Infection. The 1990 International Symposium on Viral Hepatitis and Liver Disease.

8. Fong T-L, Di Bisceglie AM, Waggoner JG, Biswas R, Hoofnagle JH. High Levels of Serum HBV-DNA and HBsAg in Acute Hepatitis B Virus Infection Predict Progression to Chronicity. Hepatology 1990;12:845.

9. Hoofnagle JH, Di Bisceglie AM, Baker B, Korenman J, Bergasa N, Fong T-L, Waggoner JG, Park Y. Treatment of Patients with Decompensated Cirrhosis Due to Chronic Hepatitis B with Recombinant Human Alpha Interferon. Hepatology 1990;12:846.

10. Di Bisceglie AM, Fong T-L, Fried MW, Swain M, Bergasa N, Shindo M, Hoofnagle JH. Ribavirin Therapy for Six Months in Patients with Chronic Hepatitis C. Gastroenterology 1991;100:A735.

11. Fong T-L, Di Bisceglie AM, Feinstone SM, Waggoner JG, Axiotis CA, Hoofnagle JH. Persistent Hepatic HBV-DNA After Clearance of HBsAg From Serum of Patients with Chronic Hepatitis. Hepatology 1991;130A;332.

12. Di Bisceglie AM, Bergasa NV, Fong T-L, Fried MW, Swain M, Baker B, Korenman J, Waggoner JG, Park Y, Hoofnagle JH. A Randomized Controlled Trial of Recombinant Alpha Interferon Therapy for Chronic Hepatitis B. Hepatology 1992:70A.

13. Fried MW, Swain MG, Fong T-L, Hayorka R, Ruddel M, Barnett JA, Hoofnagle JH, Di Bisceglie AM, Jones EA. The Monoethylglycinexylidide (MEGX) Test of Hepatic Function in Chronic Viral Hepatitis. Hepatology 1991;14;895.

14. Shindo M, Mullin EG, Di Bisceglie AM, Fong T-L, Braun-Elwert L, Hoofnagle JH Jones EA, James SP. Cytokine mRNA Expression in the Liver of Patients with Chronic Hepatitis B. Gastroenterology 1991;100:A796.

15. Fried MW, Fong T-L, Swain MG, Park Y, Simpson LH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B Virus (HBV) DNA Suppression During Long-Term Therapy with Ribavirin. Gastroenterology 1992;102:A808.

16. Shindo M, Fong T-L, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. The Physical State of the Negative Strand of HCV RNA in Serum of Infected Patients. Gastroenterology 992;102:A887.

17. Saxena S, Korula J, Fong T-L, Shulman IA. Prevalence of Hepatitis C Virus Infection and its Correlation with ALT Level Among Blood Donors at a Large Teaching Hospital. Hepatology 1992;16:220A.

18. Bergasa NV, Alling DW, Talbot TL, Swain MG, Fried MW, Fong T-L, Yurdaydin C, Schmitt JM, Walker EC, Turner ML, Jones EA. Naloxone Ameliorates the Pruritus of Cholestasis: Results of a Double-Blind Randomized Placebo-Controlled Trial. Hepatology 1992;16:152A.

19. Fong T-L, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Effect of Short-Term Prednisone Administration on Aminotransferase (ALT) Levels and HCV-RNA In Patients With Chronic Hepatitis C. Hepatology 1993;18:87A.

20. Morgan K, Peng X, Fong T-L, Kanel G, Chang C, Morgan TR. Preparation of a cDNA Library From Human Alcoholic Hepatitis Liver. Hepatology 1993;18:272A.

21. Fong T-L, Briggs WK, Valinluck B, Govindarajan S, Redeker AG. Do Patients With Normal ALT and Anti-HCV Reactivity Have Occult Infection? Hepatology 1994;20:348A.

22. Lee SR, Page E, Francis B, Fong T-L, Redeker A, Darner J, Gust C, Quan S, DiNello B, Polito A, Nelles M, Achord D. Improved Detection of Anti-HCV In Patients With Liver Disease By 3RD Generation HCV Assays. Hepatology 1994;20:240A.

23. Han S-H, Fong T-L, Valinluck B, Adkins RH, Redeker AG. Randomized Controlled Trial of the Effect of Iron Depletion on Aminotransferase Levels, HCV RNA and Response to Interferon Therapy in Patients With Chronic Hepatitis C Virus. Hepatology 1995;22:180A.

24. Han S-H, Rice S, Pedersen H, Stewart C, Reynolds TB, Fong T-L. Ultrasonogram Determination of the Hepatic Artery Resistive Index Can Accurately Diagnose Acute Alcoholic Hepatitis. Hepatology 1996;24:146A.

25. Pham T-V, Nanji AA, Fong T-L, Lin M, Yin W, Wang SC, Ohata M, Tsukamoto H. Iron and Unsaturated Fat As Nutritional Prooxidants: NF-B Activation, Induction of TNF and MIP-1 in Experimental ALD. Hepatology 1996;24:185A.

26. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Fong T-L. Prevalence Of Hepatitis C Virus Infection In Patients With B-Cell Non-Hodgkin's Lymphoma. Hepatology 1996;24:377A.

27. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Fong T-L. Is Hepatitis C Infection Associated With Severe Hepatitis In Patients With Hematological Malignancies Treated With Chemotherapy? Hepatology 1996;24:379A.

28. Han SH, Tsai N, Morgan TR, Adkins R, Redeker AG, Fong T-L. A Pilot Randomized, Controlled Trial Of The Effect Of Iron Depletion On Long-Term Response To (-Interferon In Patients With Chronic Hepatitis C Virus. Hepatology 1996;24:405A.

29. Peterson JE, Zheng J, Fong T-L, Kim JP, Kochesky R, Botla R, Redeker AG, Yun A, Geller SA, Nelles M, Lee SR. Prevalence and Persistence of Hepatitis G Virus High Risk Populations. Hepatology 1996;24:417A.

30. Zuckerman E, Tsai N, Han S-H, Redeker AG, Fong T-L. Failure of Iron Depletion to Improve Response In Chronic Hepatitis C Patients Who Were Non-Responders to Prior Interferon Treatment. Hepatology 1996;24:604A.

31. Akriviadas EA, Cohen SM, Chen DCP, Valinluck B, Stewart CA, Fong T-L.. Thrombopoietin (TPO) Levels Are Increased In Patients With Cirrhosis And Do Not Appear To Play A Role In The Pathogensis Of Thrombocytopenia Of Cirrhosis. Hepatology 1997;26:184A.

32. Peterson JE, Kochesky R, Zheng J, Chien D, Fong T-L, Kim JP., Redeker AG, Geller SA., Nelles M, Lee SR. Prevalence of Antibody to Hepatitis G Virus in High Risk Populations. Hepatology 1997;26:324A.

33. Arnaout WS, Colquhoun SD, Petrovic LM, Fong T-L, Goldman DE, Vierling JM, Shackleton CR, Busuttil RW. Late-Onset Ascites and Nodular Regenerative Hyperplasia After Liver Transplantation. Hepatology 1997;26:347A.

34. Fong T-L, Arnaout WS, Hreha GI, Rojter S, Shackleton CR, Petrovic LM, Geller SA, Villamil FG, Colquhoun SD, Vierling JM. Long Term Outcome of Transplantation for Hepatitis C. Hepatology 1999;30:245A.

35. Niven PC, Madjor D, Samson A, Lee SR, Green GA, Gwo JR, Fong T-L. Levels of Antibodies to HCV Structural Antigens Correplate with Serum HCV RNA Levels in Chronic Hepatitis C Patients Undergoing Interferon Therapy. Hepatology 1999;30:609A.

36. Fong T-L, Govindarajan S, Adkins RH, Post S, Waters RL. Prevalence of HCV Infection in Spinal Cord Injury Patients in the US. 2000 International Symposium on Viral Hepatitis and Liver Disease

37. Pruthi JS, Esrason KT, Donovan JA, Medkiff-Munsukhani KA, Paras MV, Fong T-L. Causes of Late Death in Liver Transplant Recipients. Hepatology 2000;32:254A

38. Yu AS, Colquhoun SD, Arnaout WS, Pappalardo PA, Sievers T, Geller SA, Sackleton CR, Vierling JM, Fong T-L. Lamivudine Prophylaxis Prevents Replication of HBV in Hepatitis B Core Antibody Positive Livers Following Transplantation. Hepatology 2000;32:293A

39. Fong T-L, Pauly M-P, Zacks S, Kahn JA, Sze G, Schulman D, Rodriguez-Torres M, Tsai N, Lyche K, Weston A, Han S. Multi-center randomized trial of 15 mcg Infergen administered daily vs. thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy. Hepatology 2000;32;349A Hepatology 2000;32